Concepedia

Aegera Therapeutics (Canada)

AT

Statistics

Publications

124

Citations

20.5K

Authors

9

Location

Montreal, Canada

Aegera Therapeutics (Canada) is a company institution in Montreal, Canada known for life sciences, medicine, and apoptosis.

HomepageROR

Top concepts

Publications

124

cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases that Promote RIP1 Ubiquitination

Mathieu J.M. Bertrand, Snezana Milutinovic, Kathleen M. Dickson et al. · Molecular Cell · 2008 · 1.1K citations

, , +13

Identification of XAF1 as an antagonist of XIAP anti-Caspase activity

Peter Liston, Wai Gin Fong, N. Lynn Kelly et al. · Nature Cell Biology · 2001 · 438 citations

, , +9

Expression and Genetic Analysis of XIAP-Associated Factor 1 (XAF1) in Cancer Cell Lines

Wai Gin Fong, Peter Liston, Evica Rajcan‐Separovic et al. · Genomics · 2000 · 212 citations

, , +9

Inhibitor of Apoptosis Protein cIAP2 Is Essential for Lipopolysaccharide-Induced Macrophage Survival

Damiano Conte, Martin Holčı́k, Charles Lefebvre et al. · Molecular and Cellular Biology · 2005 · 188 citations · Full text

, , +17

The Neuronal Apoptosis Inhibitory Protein Is a Direct Inhibitor of Caspases 3 and 7

Johannes Maier, Z. Lahoua, Nathalie H. Gendron et al. · Journal of Neuroscience · 2002 · 185 citations · Full text

, , +14

1–5 of 124

Authors

9

  1. AB
    Adam Belley

    Aegera Therapeutics (Canada), Canada

    47 publications · 1.3K citations

    19

    h-index

  2. IS
    Ingrid Sarmiento

    Aegera Therapeutics (Canada), Canada

    29 publications · 1.2K citations

    17

    h-index

  3. RR
    Ranga Reddy

    Aegera Therapeutics (Canada), Canada

    25 publications · 219 citations

    7

    h-index

  4. KL
    Karine Laquerre

    Aegera Therapeutics (Canada), Canada

    4 publications · 148 citations

    3

    h-index

  5. OB
    Odette Bélanger

    Aegera Therapeutics (Canada), Canada

    5 publications · 101 citations

    3

    h-index

1–5 of 9